Tianjin Lisheng Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Lisheng Pharmaceutical Company Limited with three other
companies in this sector in China:
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
sales of 849.33 million Chinese Renmimbi [US$125.81 million]
of which 100%
was Medicine Product),
Zhejiang Jolly Pharmaceutical Co Ltd
(840.04 million Chinese Renmimbi [US$124.43 million]
of which 80%
was Medicinal), and
Anhui Anke Biotechnology (Group) Company., Limited
(849.19 million Chinese Renmimbi [US$125.79 million]
of which 57%
was Biological Products).
During the year ended December of 2016, sales at
Tianjin Lisheng Pharmaceutical Company Limited were 846.83 million Chinese Renmimbi (US$125.44 million).
increase of 9.3%
versus 2015, when the company's sales were 774.67 million Chinese Renmimbi.